RecruitingNot ApplicableNCT06036199

Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects

Safety and Impact on Quality of Life of Focused Ultrasound Pallidotomy for Dyskinetic Cerebral Palsy in Pediatric and Young Adult Subjects


Sponsor

Children's National Research Institute

Enrollment

10 participants

Start Date

Jan 26, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The primary objective of the proposed study is to evaluate the safety of ExAblate Transcranial MRgFUS as a tool for creating bilateral or unilateral lesions in the globus pallidus (GPi) in patients with treatment-refractory secondary dystonia due to dyskinetic cerebral palsy


Eligibility

Min Age: 8 YearsMax Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Focused Ultrasound Pallidotomy for people with cerebral palsy, dyskinetic and secondary dystonia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 8 Years to 22 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEFocused Ultrasound Pallidotomy

Use of ExAblate Transcranial MR guided Focused Ultrasound as a tool for creating bilateral or unilateral lesions in the globus pallidus (GPi) in patients with treatment-refractory secondary dystonia due to dyskinetic cerebral palsy


Locations(1)

Children's National Hospital

Washington D.C., District of Columbia, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06036199


Related Trials